Do analysts recommend LFT or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Lument Finance Trust. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lument Finance Trust 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media prefer LFT or ADGM?

In the previous week, Lument Finance Trust and Lument Finance Trust both had 3 articles in the media. Lument Finance Trust's average media sentiment score of 1.36 beat Adagio Medical's score of 0.62 indicating that Lument Finance Trust is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lument Finance Trust 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ADGM or YHNA?

Adagio Medical presently has a consensus price target of $3.50, suggesting a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Adagio Medical is more favorable than YHN Acquisition I. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 YHN Acquisition I 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, ADGM or YHNA?

YHN Acquisition I has lower revenue, but higher earnings than Adagio Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Adagio Medical $600K 19.62 -$25.08M -$1.53 N/A YHN Acquisition I N/A N/A N/A N/A N/A

Is ADGM or YHNA more profitable?

YHN Acquisition I's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -382.50% -64.98% YHN Acquisition I N/A N/A N/A

Does the media prefer ADGM or YHNA?

In the previous week, Adagio Medical had 1 more articles in the media than YHN Acquisition I. MarketBeat recorded 3 mentions for Adagio Medical and 2 mentions for YHN Acquisition I. YHN Acquisition I's average media sentiment score of 0.93 beat Adagio Medical's score of 0.62 indicating that YHN Acquisition I is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive YHN Acquisition I 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CLPR or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts clearly believe Adagio Medical is more favorable than Clipper Realty. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clipper Realty 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media favor CLPR or ADGM?

In the previous week, Clipper Realty and Clipper Realty both had 3 articles in the media. Adagio Medical's average media sentiment score of 0.62 beat Clipper Realty's score of 0.33 indicating that Adagio Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clipper Realty 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend VHC or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Virnetx. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is VHC or ADGM more profitable?

Virnetx's return on equity of -72.84% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Virnetx N/A -72.84% -54.96% Adagio Medical N/A -382.50% -64.98%

Does the media favor VHC or ADGM?

In the previous week, Adagio Medical had 1 more articles in the media than Virnetx. MarketBeat recorded 3 mentions for Adagio Medical and 2 mentions for Virnetx. Virnetx's average media sentiment score of 0.93 beat Adagio Medical's score of 0.62 indicating that Virnetx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Virnetx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MATH or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Metalpha Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Metalpha Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation & earnings, MATH or ADGM?

Metalpha Technology has higher revenue and earnings than Adagio Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Metalpha Technology $44.57M 1.01 $15.90M N/A N/A Adagio Medical $600K 19.62 -$25.08M -$1.53 N/A

Is MATH or ADGM more profitable?

Metalpha Technology's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Metalpha Technology N/A N/A N/A Adagio Medical N/A -382.50% -64.98%

Does the media prefer MATH or ADGM?

In the previous week, Metalpha Technology and Metalpha Technology both had 3 articles in the media. Metalpha Technology's average media sentiment score of 0.96 beat Adagio Medical's score of 0.62 indicating that Metalpha Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Metalpha Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Adagio Medical (ADGM) Competitors

$0.53 0.00 (0.00%)

As of 10:26 AM Eastern

Compare

ADGM vs. LFT, YHNA, CLPR, VHC, and MATH

Should you buy Adagio Medical stock or one of its competitors? MarketBeat compares Adagio Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adagio Medical include Lument Finance Trust (LFT), YHN Acquisition I (YHNA), Clipper Realty (CLPR), Virnetx (VHC), and Metalpha Technology (MATH). These companies are all part of the "trading" industry.

How does Adagio Medical compare to Lument Finance Trust?

Lument Finance Trust (NYSE:LFT) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

Lument Finance Trust has higher revenue and earnings than Adagio Medical. Lument Finance Trust is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lument Finance Trust	$79M	0.62	-$2.74M	-$0.13	N/A
Adagio Medical	$600K	19.62	-$25.08M	-$1.53	N/A

Adagio Medical has a net margin of 0.00% compared to Lument Finance Trust's net margin of -2.59%. Lument Finance Trust's return on equity of 5.65% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lument Finance Trust	-2.59%	5.65%	0.86%
Adagio Medical	N/A	-382.50%	-64.98%

In the previous week, Lument Finance Trust and Lument Finance Trust both had 3 articles in the media. Lument Finance Trust's average media sentiment score of 1.36 beat Adagio Medical's score of 0.62 indicating that Lument Finance Trust is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lument Finance Trust	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Lument Finance Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lument Finance Trust	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Lument Finance Trust has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, suggesting that its share price is 119% less volatile than the broader market.

19.5% of Lument Finance Trust shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 3.3% of Lument Finance Trust shares are owned by insiders. Comparatively, 7.8% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Adagio Medical beats Lument Finance Trust on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to YHN Acquisition I?

Adagio Medical (NASDAQ:ADGM) and YHN Acquisition I (NASDAQ:YHNA) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Adagio Medical has a beta of -0.19, meaning that its share price is 119% less volatile than the broader market. Comparatively, YHN Acquisition I has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market.

Adagio Medical presently has a consensus price target of $3.50, suggesting a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Adagio Medical is more favorable than YHN Acquisition I.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
YHN Acquisition I	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Adagio Medical had 1 more articles in the media than YHN Acquisition I. MarketBeat recorded 3 mentions for Adagio Medical and 2 mentions for YHN Acquisition I. YHN Acquisition I's average media sentiment score of 0.93 beat Adagio Medical's score of 0.62 indicating that YHN Acquisition I is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
YHN Acquisition I	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

YHN Acquisition I has lower revenue, but higher earnings than Adagio Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	19.62	-$25.08M	-$1.53	N/A
YHN Acquisition I	N/A	N/A	N/A	N/A	N/A

48.1% of Adagio Medical shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by insiders. Comparatively, 1.4% of YHN Acquisition I shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

YHN Acquisition I's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-382.50%	-64.98%
YHN Acquisition I	N/A	N/A	N/A

Summary

Adagio Medical beats YHN Acquisition I on 7 of the 11 factors compared between the two stocks.

How does Adagio Medical compare to Clipper Realty?

Clipper Realty (NYSE:CLPR) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

37.6% of Clipper Realty shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 54.6% of Clipper Realty shares are owned by company insiders. Comparatively, 7.8% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Clipper Realty has higher revenue and earnings than Adagio Medical. Clipper Realty is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clipper Realty	$153.20M	0.30	-$19.90M	-$0.81	N/A
Adagio Medical	$600K	19.62	-$25.08M	-$1.53	N/A

Adagio Medical has a net margin of 0.00% compared to Clipper Realty's net margin of -7.10%. Clipper Realty's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clipper Realty	-7.10%	N/A	-0.87%
Adagio Medical	N/A	-382.50%	-64.98%

Clipper Realty has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, indicating that its share price is 119% less volatile than the broader market.

In the previous week, Clipper Realty and Clipper Realty both had 3 articles in the media. Adagio Medical's average media sentiment score of 0.62 beat Clipper Realty's score of 0.33 indicating that Adagio Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clipper Realty	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts clearly believe Adagio Medical is more favorable than Clipper Realty.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clipper Realty	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Adagio Medical beats Clipper Realty on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Virnetx?

Virnetx (NASDAQ:VHC) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Virnetx's return on equity of -72.84% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Virnetx	N/A	-72.84%	-54.96%
Adagio Medical	N/A	-382.50%	-64.98%

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 560.38%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Virnetx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Adagio Medical had 1 more articles in the media than Virnetx. MarketBeat recorded 3 mentions for Adagio Medical and 2 mentions for Virnetx. Virnetx's average media sentiment score of 0.93 beat Adagio Medical's score of 0.62 indicating that Virnetx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Virnetx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

10.4% of Virnetx shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 15.7% of Virnetx shares are held by company insiders. Comparatively, 7.8% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Virnetx has a beta of 2.29, suggesting that its stock price is 129% more volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, suggesting that its stock price is 119% less volatile than the broader market.

Virnetx has higher earnings, but lower revenue than Adagio Medical. Virnetx is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virnetx	$160K	285.44	-$18.23M	-$5.16	N/A
Adagio Medical	$600K	19.62	-$25.08M	-$1.53	N/A

Summary

Adagio Medical beats Virnetx on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Metalpha Technology?

Metalpha Technology (NASDAQ:MATH) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

In the previous week, Metalpha Technology and Metalpha Technology both had 3 articles in the media. Metalpha Technology's average media sentiment score of 0.96 beat Adagio Medical's score of 0.62 indicating that Metalpha Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Metalpha Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Metalpha Technology	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Metalpha Technology's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Metalpha Technology	N/A	N/A	N/A
Adagio Medical	N/A	-382.50%	-64.98%

Metalpha Technology has a beta of -0.66, meaning that its stock price is 166% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, meaning that its stock price is 119% less volatile than the broader market.

Metalpha Technology has higher revenue and earnings than Adagio Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Metalpha Technology	$44.57M	1.01	$15.90M	N/A	N/A
Adagio Medical	$600K	19.62	-$25.08M	-$1.53	N/A

30.5% of Metalpha Technology shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 5.9% of Metalpha Technology shares are owned by company insiders. Comparatively, 7.8% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Adagio Medical beats Metalpha Technology on 7 of the 12 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADGM vs. The Competition

Export

Metric	Adagio Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$11.77M	$7.41B	$6.91B	$12.20B
Dividend Yield	N/A	1.33%	2.68%	8.87%
P/E Ratio	-0.35	50.18	27.23	23.90
Price / Sales	19.62	80.46	573.53	111.21
Price / Cash	N/A	26.61	49.25	59.89
Price / Book	0.90	7.11	10.85	6.19
Net Income	-$25.08M	$162.30M	$3.59B	$331.84M
7 Day Performance	-7.02%	-2.37%	-2.26%	-2.30%
1 Month Performance	-24.29%	-0.64%	1.89%	-1.63%
1 Year Performance	-64.67%	3.87%	23.86%	16.11%

Adagio Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADGM Adagio Medical	2.9783 of 5 stars	$0.53 flat	$3.50 +560.4%	-63.4%	$11.77M	$600K	N/A	87	Gap Up
LFT Lument Finance Trust	2.3272 of 5 stars	$0.92 -1.2%	N/A	-56.7%	$48.40M	$79M	N/A	600	Positive News
YHNA YHN Acquisition I	0.5486 of 5 stars	$10.95 +0.8%	N/A	+5.6%	$46.98M	N/A	N/A	N/A	High Trading Volume
CLPR Clipper Realty	1.3126 of 5 stars	$2.89 +0.5%	N/A	-25.8%	$46.62M	$153.20M	N/A	140
VHC Virnetx	0.2158 of 5 stars	$10.92 +6.8%	N/A	N/A	$45.74M	$160K	N/A	20	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADGM) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adagio Medical (ADGM) Competitors

ADGM vs. LFT, YHNA, CLPR, VHC, and MATH

How does Adagio Medical compare to Lument Finance Trust?

Summary

How does Adagio Medical compare to YHN Acquisition I?

Summary

How does Adagio Medical compare to Clipper Realty?

Summary

How does Adagio Medical compare to Virnetx?

Summary

How does Adagio Medical compare to Metalpha Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adagio Medical (ADGM) Competitors

ADGM vs. LFT, YHNA, CLPR, VHC, and MATH

How does Adagio Medical compare to Lument Finance Trust?

Which has better valuation and earnings, LFT or ADGM?

Is LFT or ADGM more profitable?

Does the media prefer LFT or ADGM?

Do analysts recommend LFT or ADGM?

Which has more risk & volatility, LFT or ADGM?

Do insiders and institutionals have more ownership in LFT or ADGM?

Summary

How does Adagio Medical compare to YHN Acquisition I?

Which has more risk & volatility, ADGM or YHNA?

Do analysts recommend ADGM or YHNA?

Does the media prefer ADGM or YHNA?

Which has better earnings & valuation, ADGM or YHNA?

Do insiders and institutionals hold more shares of ADGM or YHNA?

Is ADGM or YHNA more profitable?

Summary

How does Adagio Medical compare to Clipper Realty?

Do institutionals and insiders believe in CLPR or ADGM?

Which has higher valuation and earnings, CLPR or ADGM?

Is CLPR or ADGM more profitable?

Which has more risk and volatility, CLPR or ADGM?

Does the media favor CLPR or ADGM?

Do analysts prefer CLPR or ADGM?

Summary

How does Adagio Medical compare to Virnetx?

Is VHC or ADGM more profitable?

Do analysts recommend VHC or ADGM?

Does the media favor VHC or ADGM?

Do institutionals & insiders believe in VHC or ADGM?

Which has more risk & volatility, VHC or ADGM?

Which has better valuation & earnings, VHC or ADGM?

Summary

How does Adagio Medical compare to Metalpha Technology?

Does the media prefer MATH or ADGM?

Do analysts prefer MATH or ADGM?

Is MATH or ADGM more profitable?

Which has more volatility & risk, MATH or ADGM?

Which has stronger valuation & earnings, MATH or ADGM?

Do insiders and institutionals have more ownership in MATH or ADGM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools